The Endpoint Podcast: A Clinical Trial Podcast Wed, 06 May 2026 04:58:33 -0400 https://theendpointpodcastaclinicaltrialpodcast.buzzsprout.com en-us © 2026 The Endpoint Podcast: A Clinical Trial Podcast yes c8b1b7d7-9caa-5366-972f-b983bd1c5021 Liam Eves episodic false Join me on my journey across the clinical trial landscape. I will be accompanied by a variety of people, all experts within their field, as we seek to understand and uncover unknowns, to shape ideas, inspire innovation and ultimately to find out how we can truly move clinical trials out of the spiralling void of higher costs and lower outputs. Click on an episode below to listen.

]]> Buzzsprout (https://www.buzzsprout.com) Liam Eves https://storage.buzzsprout.com/fqnsypw9mera795vurpcf41eoz6k?.jpg The Endpoint Podcast: A Clinical Trial Podcast The Endpoint Podcast. Episode 35: With Aqil Ahsan and Jaseem Mahmmdla, Kognitic The Endpoint Podcast. Episode 35: With Aqil Ahsan and Jaseem Mahmmdla, Kognitic On this week's podcast, Liam is joined by Aqil Ahsan, the founder and CEO of Kognitic, and Jaseem Mahmmdla, the co-founder and technologist behind their innovative AI-driven platform. Aqil has a background in mechanical engineering, having worked in automotive and aerospace industries, where he developed a passion for automation. Jaseem brings over 25 years of experience as a technologist with expertise in data analysis and product design, focusing on improving drug development processes. These passions led them to co-found Kognitic, applying automation and advanced technology to the clinical trial space.

In this episode, we explore how automation and AI are reshaping the pharmaceutical industry, delving into the challenges of data collection, patient recruitment, and trial efficiency. We discuss the importance of real-world evidence, efficacy benchmarking, and the critical role of natural language processing in accelerating drug development. The conversation also touches on the gap between pharma and other industries in adopting automation and the potential of AI to revolutionize clinical trials. Prepare for an insightful discussion on the future of drug development and how AI is transforming the industry and much more.

]]> On this week's podcast, Liam is joined by Aqil Ahsan, the founder and CEO of Kognitic, and Jaseem Mahmmdla, the co-founder and technologist behind their innovative AI-driven platform. Aqil has a background in mechanical engineering, having worked in automotive and aerospace industries, where he developed a passion for automation. Jaseem brings over 25 years of experience as a technologist with expertise in data analysis and product design, focusing on improving drug development processes. These passions led them to co-found Kognitic, applying automation and advanced technology to the clinical trial space.

In this episode, we explore how automation and AI are reshaping the pharmaceutical industry, delving into the challenges of data collection, patient recruitment, and trial efficiency. We discuss the importance of real-world evidence, efficacy benchmarking, and the critical role of natural language processing in accelerating drug development. The conversation also touches on the gap between pharma and other industries in adopting automation and the potential of AI to revolutionize clinical trials. Prepare for an insightful discussion on the future of drug development and how AI is transforming the industry and much more.

]]> Liam Eves Buzzsprout-15975322 Wed, 23 Oct 2024 09:00:00 +0000 2589 35 full false The Endpoint Podcast. Episode 34: With Ilya Gluhovsky and Paul Neyman. Areti Health The Endpoint Podcast. Episode 34: With Ilya Gluhovsky and Paul Neyman. Areti Health Ilya Gluhovsky and Paul Neyman join Liam on this week’s podcast episode. Ilya has an extensive background in software development, machine learning, and AI, with leadership roles in companies like Ancestry.com and Rally Health, and is now the co-founder of Areti Health, a company focused on revolutionizing patient recruitment in clinical trials using generative AI. Paul, with a background in computer science and sales, has successfully scaled multiple startups and now drives the sales strategy at Areti Health. In our discussion today, we dive into the challenges of patient recruitment in clinical trials, explore how generative AI is transforming the process, discuss the importance of personalized and culturally sensitive patient engagement, and uncover the future potential of AI in improving clinical trial efficiency and outcomes. We also touch on the misconceptions about AI in healthcare and a new standard for patient interaction and retention in clinical research, and much more.

]]> Ilya Gluhovsky and Paul Neyman join Liam on this week’s podcast episode. Ilya has an extensive background in software development, machine learning, and AI, with leadership roles in companies like Ancestry.com and Rally Health, and is now the co-founder of Areti Health, a company focused on revolutionizing patient recruitment in clinical trials using generative AI. Paul, with a background in computer science and sales, has successfully scaled multiple startups and now drives the sales strategy at Areti Health. In our discussion today, we dive into the challenges of patient recruitment in clinical trials, explore how generative AI is transforming the process, discuss the importance of personalized and culturally sensitive patient engagement, and uncover the future potential of AI in improving clinical trial efficiency and outcomes. We also touch on the misconceptions about AI in healthcare and a new standard for patient interaction and retention in clinical research, and much more.

]]> Liam Eves Buzzsprout-15805994 Tue, 24 Sep 2024 09:00:00 +0000 2746 34 full false The Endpoint Podcast. Episode 33: With Scott Burgher. Head of Patient Experience Operations, Verily The Endpoint Podcast. Episode 33: With Scott Burgher. Head of Patient Experience Operations, Verily Scott joins Liam on this week’s podcast episode. Scott has built an impressive career focused on patient recruitment and experience and DCT across several prominent companies, including Accenture, Verily, and also is a part of Decentralized Trials & Research Alliance (DTRA) as a Member Board of Directors. In our discussion today, we delve into a range of topics relating to recruitment and patient experience, we discuss what patient centricity means, explore how Scott would deliver clinical trials if he had a blank canvas, we explore what most people don’t know about patient recruitment and uncover what innovations Scott is most excited about and much more.

]]> Scott joins Liam on this week’s podcast episode. Scott has built an impressive career focused on patient recruitment and experience and DCT across several prominent companies, including Accenture, Verily, and also is a part of Decentralized Trials & Research Alliance (DTRA) as a Member Board of Directors. In our discussion today, we delve into a range of topics relating to recruitment and patient experience, we discuss what patient centricity means, explore how Scott would deliver clinical trials if he had a blank canvas, we explore what most people don’t know about patient recruitment and uncover what innovations Scott is most excited about and much more.

]]> Liam Eves Buzzsprout-15732685 Wed, 11 Sep 2024 10:00:00 +0000 2215 33 full false The Endpoint Podcast. Episode 32: With Sandy Robbins, VP Commercial Operations at MMS The Endpoint Podcast. Episode 32: With Sandy Robbins, VP Commercial Operations at MMS Sandy joins Liam on this week’s podcast episode. Sandy is the Vice President of Commercial Operations at MMS. Sandy has built an impressive career focused on strategic pricing across several prominent companies, including Syneos, PPD, Quintiles, and more. In our discussion today, we delve into a range of critical topics, including the distinction between price and value in the industry, what’s broken in the current trial model between sponsors, CROs, and sites, and why we shouldn’t rely on past pricing models to shape the future. Additionally, we explore Sandy's backstory on how she entered the clinical trials space, her unique process for helping groups demonstrate value over price, and much more.

]]> Sandy joins Liam on this week’s podcast episode. Sandy is the Vice President of Commercial Operations at MMS. Sandy has built an impressive career focused on strategic pricing across several prominent companies, including Syneos, PPD, Quintiles, and more. In our discussion today, we delve into a range of critical topics, including the distinction between price and value in the industry, what’s broken in the current trial model between sponsors, CROs, and sites, and why we shouldn’t rely on past pricing models to shape the future. Additionally, we explore Sandy's backstory on how she entered the clinical trials space, her unique process for helping groups demonstrate value over price, and much more.

]]> Liam Eves Buzzsprout-15680346 Mon, 02 Sep 2024 05:00:00 +0000 1940 32 full false The Endpoint Podcast. Episode 31: With Jeff Smith, Experienced CRO CEO, Strategic Advisor & Consultant The Endpoint Podcast. Episode 31: With Jeff Smith, Experienced CRO CEO, Strategic Advisor & Consultant Jeff joins Liam on this week’s podcast episode. Jeff is a seasoned executive within the pharma and CRO space. Jeff is currently the President at The Luna Group Consulting. He was previously the CEO of Alimentiv, in which he scaled it from an academic spin out to a specialised CRO focused on GI. In our discussion today we discuss all things CRO, we understand how the space works, the relationships amongst stakeholders, understand where the industry gets it right and wrong and take a deep dive on leadership and so much more.

]]> Jeff joins Liam on this week’s podcast episode. Jeff is a seasoned executive within the pharma and CRO space. Jeff is currently the President at The Luna Group Consulting. He was previously the CEO of Alimentiv, in which he scaled it from an academic spin out to a specialised CRO focused on GI. In our discussion today we discuss all things CRO, we understand how the space works, the relationships amongst stakeholders, understand where the industry gets it right and wrong and take a deep dive on leadership and so much more.

]]> Liam Eves Buzzsprout-15196245 Wed, 05 Jun 2024 06:00:00 +0000 2796 31 full false The Endpoint Podcast. Episode 30: With Ted Trafford. Business Development at Probity Medical Research The Endpoint Podcast. Episode 30: With Ted Trafford. Business Development at Probity Medical Research Ted joins Liam on this week’s podcast episode. Ted is the Director of Business Development at Probity Medical Research. Probity Medical Research (PMR) is a leading clinical research consortium with over 70 clinical trials sites. PMR's network conducts clinical trials in Aesthetics, Allergy / Immunology, Cardiology, Dermatology, Rheumatology and Vaccines. In todays session we explore all things enrollment. We discuss the psychology at sites, how to create a high performing site, the relationships between site, CRO’s and Sponsors, investing in sites, and throw in a few stories and analogies for good measure!

]]> Ted joins Liam on this week’s podcast episode. Ted is the Director of Business Development at Probity Medical Research. Probity Medical Research (PMR) is a leading clinical research consortium with over 70 clinical trials sites. PMR's network conducts clinical trials in Aesthetics, Allergy / Immunology, Cardiology, Dermatology, Rheumatology and Vaccines. In todays session we explore all things enrollment. We discuss the psychology at sites, how to create a high performing site, the relationships between site, CRO’s and Sponsors, investing in sites, and throw in a few stories and analogies for good measure!

]]> Liam Eves Buzzsprout-15159400 Wed, 29 May 2024 20:00:00 +0000 3149 30 full false The Endpoint Podcast. Episode 29: With Scott Schliebner, VP and Global Head of Drug Development Consulting, Novotech The Endpoint Podcast. Episode 29: With Scott Schliebner, VP and Global Head of Drug Development Consulting, Novotech Scott join Liam on this week’s podcast episode. Scott is VP and Global Head of Drug Development at Novotech. Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase. In todays session we explore Scott’s origin story, discuss it means to him to put patients first, dive into ways we can deliver trials differently and some of his biggest lessons learned over the years in the clinical trial space and much more!

]]> Scott join Liam on this week’s podcast episode. Scott is VP and Global Head of Drug Development at Novotech. Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase. In todays session we explore Scott’s origin story, discuss it means to him to put patients first, dive into ways we can deliver trials differently and some of his biggest lessons learned over the years in the clinical trial space and much more!

]]> Liam Eves Buzzsprout-15072455 Wed, 15 May 2024 10:00:00 +0000 2566 28 full false The Endpoint Podcast. Episode 28: With Kris Larson. Director of Client Engagement at Six Degrees The Endpoint Podcast. Episode 28: With Kris Larson. Director of Client Engagement at Six Degrees Todays Guest is Kris Larson. Kris has 25+ years of global experience in brand development across a variety of sectors - including Life science. He is currently the Director of Client Engagement at Six Degrees. Six Degrees is a Psycho-Sensory Brand Building Agency. The company focuses on combining psychology-based tools and techniques with sensory branding methods to create real and lasting brand impact.

In this session we dive into understanding what psycho-sentory branding is and the value it has in clinical trials.

]]> Todays Guest is Kris Larson. Kris has 25+ years of global experience in brand development across a variety of sectors - including Life science. He is currently the Director of Client Engagement at Six Degrees. Six Degrees is a Psycho-Sensory Brand Building Agency. The company focuses on combining psychology-based tools and techniques with sensory branding methods to create real and lasting brand impact.

In this session we dive into understanding what psycho-sentory branding is and the value it has in clinical trials.

]]> Liam Eves Buzzsprout-15031568 Wed, 08 May 2024 04:00:00 +0000 2388 27 full false The Endpoint Podcast. Episode 27: With Jenn McNary and Richie Kahn. Founders, Canary Advisors The Endpoint Podcast. Episode 27: With Jenn McNary and Richie Kahn. Founders, Canary Advisors Jenn and Richie join Liam on this week’s podcast episode. Jenn and Richie are founders of Canary Advisors. Canary Advisors is a boutique consultancy that works with organizations on patient focused drug and device development. They work with biopharmaceutical, nonprofit, and regulatory groups to better understand disease impacts, unmet needs, and patient preferences. In todays session we discuss what patient advocacy is, where do Sponsors get it wrong and what we can do about it and understand the patient FDA process and much more.

]]> Jenn and Richie join Liam on this week’s podcast episode. Jenn and Richie are founders of Canary Advisors. Canary Advisors is a boutique consultancy that works with organizations on patient focused drug and device development. They work with biopharmaceutical, nonprofit, and regulatory groups to better understand disease impacts, unmet needs, and patient preferences. In todays session we discuss what patient advocacy is, where do Sponsors get it wrong and what we can do about it and understand the patient FDA process and much more.

]]> Liam Eves Buzzsprout-14925799 Sun, 21 Apr 2024 09:00:00 +0000 2594 26 full false The Endpoint Podcast. Episode 26: With Joel White. Founder, Marketcap Consulting The Endpoint Podcast. Episode 26: With Joel White. Founder, Marketcap Consulting Joel White joins Liam on this week’s podcast episode. Joel founded Marketcap Consulting, LLC in 2021 to help companies increase the valuation and effectiveness of their business by improving their financial performance and strategy. Prior to this he has worked with groups such as Synteract, Chiltern, Parexel, PRA. In todays session we discuss the current clinical trial landscape and economy, discuss how to price services and talk about current tension between CRO’s and sites and much more.

]]> Joel White joins Liam on this week’s podcast episode. Joel founded Marketcap Consulting, LLC in 2021 to help companies increase the valuation and effectiveness of their business by improving their financial performance and strategy. Prior to this he has worked with groups such as Synteract, Chiltern, Parexel, PRA. In todays session we discuss the current clinical trial landscape and economy, discuss how to price services and talk about current tension between CRO’s and sites and much more.

]]> Liam Eves Buzzsprout-14791043 Fri, 29 Mar 2024 08:00:00 +0000 2704 26 full false The Endpoint Podcast. Episode 25: With Vatche Bartekian, Founder and President at Vantage BioTrials The Endpoint Podcast. Episode 25: With Vatche Bartekian, Founder and President at Vantage BioTrials Vatche Bartekian joins Liam on this week’s podcast episode. Vatche is the Founder and President at Vantage BioTrials. Vantage BioTrials is a Canadian CRO that delivers clinical trial management services to clients in the pharmaceutical, biotechnology, and medical device sectors. Prior to this Vatche worked with groups such as Pfizer, Covance and PPD. In todays session we discuss about the concept of quality by design, how AI could support research and much more.

]]> Vatche Bartekian joins Liam on this week’s podcast episode. Vatche is the Founder and President at Vantage BioTrials. Vantage BioTrials is a Canadian CRO that delivers clinical trial management services to clients in the pharmaceutical, biotechnology, and medical device sectors. Prior to this Vatche worked with groups such as Pfizer, Covance and PPD. In todays session we discuss about the concept of quality by design, how AI could support research and much more.

]]> Liam Eves Buzzsprout-14728668 Wed, 20 Mar 2024 10:00:00 +0000 2546 25 full false The Endpoint Podcast. Episode 24: With Vincent Cafiso. Founder, Managing Consultant at Practical Compliance Results The Endpoint Podcast. Episode 24: With Vincent Cafiso. Founder, Managing Consultant at Practical Compliance Results Vincent Cafiso joins Liam on this week’s podcast episode. Vin is the founder and Managing Consultant at Practical Compliance Results. It’s here that Vin helps medical device and IVD companies be ready for FDA inspection. In this session, we discuss a wide range of topics relating to compliance, quality assurance and quality systems. We discuss the principles of regulation and how companies can prepare for inspections and audits and much more.

]]> Vincent Cafiso joins Liam on this week’s podcast episode. Vin is the founder and Managing Consultant at Practical Compliance Results. It’s here that Vin helps medical device and IVD companies be ready for FDA inspection. In this session, we discuss a wide range of topics relating to compliance, quality assurance and quality systems. We discuss the principles of regulation and how companies can prepare for inspections and audits and much more.

]]> Liam Eves Buzzsprout-14676396 Tue, 12 Mar 2024 14:00:00 +0000 2514 24 full false The Endpoint Podcast. Episode 23: With Scott Whitt. President and General Manager of Triad Clinical Trials The Endpoint Podcast. Episode 23: With Scott Whitt. President and General Manager of Triad Clinical Trials Scott Whitt joins Liam on this week’s podcast episode. Scott is the President and General Manager of Triad Clinical Trials, a premier research clinic located in Greensboro, North Carolina that serves the Triad region. In this session, we discuss topics including Scott's journey from consulting for firms such as IQVIA, Deloitte, and United Health to buying a clinical research site. We explore the dynamic and kinetic world of research. We dive into how he and his team tripled Triad’s performance, discuss some misalignments with site and sponsor, and much more.

]]> Scott Whitt joins Liam on this week’s podcast episode. Scott is the President and General Manager of Triad Clinical Trials, a premier research clinic located in Greensboro, North Carolina that serves the Triad region. In this session, we discuss topics including Scott's journey from consulting for firms such as IQVIA, Deloitte, and United Health to buying a clinical research site. We explore the dynamic and kinetic world of research. We dive into how he and his team tripled Triad’s performance, discuss some misalignments with site and sponsor, and much more.

]]> Liam Eves Buzzsprout-14637656 Wed, 06 Mar 2024 07:00:00 +0000 2733 23 full false The Endpoint Podcast. Episode 22: With Tiffany Ashton. Director of Operations, ClinEssentials The Endpoint Podcast. Episode 22: With Tiffany Ashton. Director of Operations, ClinEssentials Tiffany Ashton joins Liam on this week’s podcast episode. Tiffany is the Director of Operations at ClinEssentials. ClinEssentials provides training and tools for Clinical Research Associates (CRA), Clinical Trial Managers (CTMs), and more. In this session, we explore a range of topics including Tiffany’s journey into clinical trials, some of the problems in clinical trials as a CTA and CTM, how you can solve them, considerations for Biotech and Pharma when operationalising their study, and much more

]]> Tiffany Ashton joins Liam on this week’s podcast episode. Tiffany is the Director of Operations at ClinEssentials. ClinEssentials provides training and tools for Clinical Research Associates (CRA), Clinical Trial Managers (CTMs), and more. In this session, we explore a range of topics including Tiffany’s journey into clinical trials, some of the problems in clinical trials as a CTA and CTM, how you can solve them, considerations for Biotech and Pharma when operationalising their study, and much more

]]> Liam Eves Buzzsprout-14591749 Wed, 28 Feb 2024 07:00:00 +0000 2079 22 full false The Endpoint Podcast. Episode 21 with Dan Sfera. Co-Founder of Yuma Clinical Trials The Endpoint Podcast. Episode 21 with Dan Sfera. Co-Founder of Yuma Clinical Trials Dan Sfera joins Liam on this week’s podcast episode. Dan is Co-Founder of Yuma Clinical Trials. Yuma conduct multi-therapeutic clinical trials and align with clinicians and specialists to bring study opportunities to the underserved Southwestern Arizona region. Dan is also the Co-Founder of CRA Academy, and owner of The Clinical Trial Guru, where he shares his knowledge of clinical trials. In this session we explore a range of topics including, Dan’s journey into clinical trials, some of the problems of running a research centre and how he solves them and much more. 

]]> Dan Sfera joins Liam on this week’s podcast episode. Dan is Co-Founder of Yuma Clinical Trials. Yuma conduct multi-therapeutic clinical trials and align with clinicians and specialists to bring study opportunities to the underserved Southwestern Arizona region. Dan is also the Co-Founder of CRA Academy, and owner of The Clinical Trial Guru, where he shares his knowledge of clinical trials. In this session we explore a range of topics including, Dan’s journey into clinical trials, some of the problems of running a research centre and how he solves them and much more. 

]]> Liam Eves Buzzsprout-14545266 Wed, 21 Feb 2024 11:00:00 +0000 3037 21 full false The Endpoint Podcast. Episode 20: With Stacy Hurt. Chief Patient Officer at Parexel The Endpoint Podcast. Episode 20: With Stacy Hurt. Chief Patient Officer at Parexel Stacy Hurt joins Liam on this week’s podcast episode. Stacy is the Chef Patient Officer (CPO) at Parexel. It’s one of the largest clinical research organizations (CROs) and provides the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. In this session we explore a range of topics including, Stacy’s inspiring journey from caring for her son and battling cancer to becoming a patient advocate, along with other topics such as how in her new role as CPO she is leading the charge on helps Sponsors be more patient centric and much more.

]]> Stacy Hurt joins Liam on this week’s podcast episode. Stacy is the Chef Patient Officer (CPO) at Parexel. It’s one of the largest clinical research organizations (CROs) and provides the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. In this session we explore a range of topics including, Stacy’s inspiring journey from caring for her son and battling cancer to becoming a patient advocate, along with other topics such as how in her new role as CPO she is leading the charge on helps Sponsors be more patient centric and much more.

]]> Liam Eves Buzzsprout-14485193 Mon, 12 Feb 2024 08:00:00 +0000 2398 20 full false